MSOS News

High Alert Assessment Participants Can Access Comparative Data Workbook
Post date: 3 weeks 5 days ago

The preliminary comparative data from the ISMP Medication Safety Self Assessment® for High-Alert Medications is now available online to participants who submitted their findings to ISMP. The quality improvement workbook contains aggregate data that can be used by participants to compare their results to the aggregate results of demographically similar US facilities. Inpatient, outpatient, and prioritization worksheets are provided. 

MSOS members, please join us for our June Member Briefing webinar being held next Thursday, June 28th at 1 pm ET.
Post date: 3 weeks 5 days ago

Shedding Light on a Black Hole: Local Anesthetic Use in the Pediatric OR
Meghan Rowcliffe PharmD, BCPS, BCPPS Medication Safety Officer, Pediatrics The Johns Hopkins Hospital

Avoiding harm: A Focus on the REMS Program for alemtuzumab (Lemtrada)
Jamie Wilkins, PharmD
Deputy Director, Division of Risk Management, Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, CDER, FDA

Update on the ISMP Smart Infusion Pump Summit
Michelle Mandrack, MSN, Director of Consulting Services, ISMP
David Valentine, PharmD, 2017-2018 ISMP Safe Medication Management Fellow

Update from ISMP
Michael Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP, President, ISMP

 

June MSOS Member Briefing Webinar
Post date: 1 month 2 weeks ago

Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, June 28, 2018 from 1:00-2:00 pm ET.

Short medication safety-related presentations for this webinar will include:

Alert on Safe Handling of Concentrated Electrolyte Products During Shortages
Post date: 1 month 2 weeks ago

A National Alert Network (NAN) alert was recently sent out regarding the safe handling of concentrated electrolyte products from outsourcing facilities during critical drug shortages. These products, particularly concentrated potassium chloride, may be provided by outsourcing facilities in syringes or vials without the same labeling required by USP for commercially available products. Special precautions should be taken to prevent these products from being dispensed from the pharmacy undiluted, and inadvertently administered which could result in a fatality. Please share this alert with your staff and colleagues. https://www.ismp.org/sites/default/files/attachments/2018-05/NAN%20Alert%2020180524.pdf

read more...

The mission of the Medication Safety Officers Society (MSOS) is to advance and encourage excellence in safe medication use by providing communication, leadership, direction, and education among its members.